Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | REN | P00797 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5967438 | 0.86 | — | — | |
| SCHEMBL6559712 | 0.80 | ALDH1A1 (0.37) | FFAR1ALDH1A1ALOX5RENACE | |
| SCHEMBL28237087 | 0.77 | ALDH1A1 (0.39) | FFAR1ALDH1A1ALOX5RENACE | |
| SCHEMBL6808670 | 0.76 | ALDH1A1 (0.55) | ALDH1A1RENACE | |
| SCHEMBL8651989 | 0.76 | ALDH1A1 (0.55) | ALDH1A1RENACE | |
| SCHEMBL1208925 | 0.76 | ALDH1A1 (0.55) | ALDH1A1RENACE | |
| Hydrochloric Acid SCHEMBL25376746 | 0.76 | ALDH1A1 (0.38) | FFAR1ALDH1A1ALOX5RENACE | |
| Hydrochloric Acid SCHEMBL25376742 | 0.76 | ALDH1A1 (0.38) | FFAR1ALDH1A1ALOX5RENACE | |
| SCHEMBL2951714 | 0.75 | ALOX5 (0.35) | ALOX5ACEL3MBTL3 | |
| SCHEMBL2951716 | 0.75 | ALOX5 (0.35) | ALOX5ACEL3MBTL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7868036-B2 | Organic compounds | NOVARTIS AG (CH) | 2011-01-11 | — | — | US | disclosed |
| US-20080058320-A1 | Organic Compounds | NOVARTIS AG (CH) | 2008-03-06 | — | — | US | disclosed |
| CN-1934082-A | Organic compounds | SPEEDEL EXPERIMENTA AG (CH) | 2007-03-21 | — | — | CN | disclosed |
| EP-1725530-A1 | ORGANIC COMPOUNDS | Speedel Experimenta AG (CH) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005090304-A1 | ORGANIC COMPOUNDS | SPEEDEL EXPERIMENTA AG (CH) | 2005-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058320-A1 | Organic Compounds | REN, AGTR1, ADH1C | FFAR1 495/4885ALDH1A1 77/4885ALOX5 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.